How effective is Tacrolimus for Kidney Transplant Rejection ?


13 Tacrolimus users have rated its effectiveness for Kidney transplant rejection.

Overall ratings: 3.9/5
Long term ratings: 4/5

This is a reivew of how effective Tacrolimus (tacrolimus) is for Kidney transplant rejection and for what kind of people. The study is created by eHealthMe and is updated continuously.


On Jun, 11, 2018

13 people are studied for taking Tacrolimus in Kidney transplant rejection


Overall effectiveness (number of people)

Does Tacrolimus work for your Kidney transplant rejection (overall)?

Long term effectiveness (number of people)

Does Tacrolimus work for your Kidney transplant rejection (long term)?

Tacrolimus effectiveness for Kidney transplant rejection (number of people)

Overall:
  • not at all: 0
  • somewhat: 0
  • moderate: 5
  • high: 4
  • very high: 4
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 3
  • high: 3
  • very high: 3

Gender of people who take Tacrolimus for Kidney transplant rejection *

  • female: 46.15 %
  • male: 53.85 %

Age of people who take Tacrolimus for Kidney transplant rejection *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 7.69 %
  • 20-29: 30.77 %
  • 30-39: 23.08 %
  • 40-49: 0.0 %
  • 50-59: 15.38 %
  • 60+: 23.08 %

Who finds Tacrolimus more effective for Kidney Transplant Rejection?


Gender of people who take Tacrolimus for Kidney transplant rejection *

  • female: 50 %
  • male: 50 %

Age of people who take Tacrolimus for Kidney transplant rejection *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 37.5 %
  • 30-39: 12.5 %
  • 40-49: 0.0 %
  • 50-59: 25.0 %
  • 60+: 25.0 %

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you take Tacrolimus for Kidney transplant rejection? Connect with people like you, or share your experience to help people like you

Tacrolimus

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. (latest outcomes from Tacrolimus 28,913 users)

Kidney Transplant Rejection

Kidney transplant rejection has been reported by people with kidney transplant, immunodeficiency disorders, high blood pressure, preventive health care, kidney transplant rejection (latest reports from 4,985 Kidney transplant rejection patients).

Related studies:

Analysis tools (to study 615 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Tacrolimus, Kidney transplant rejection



Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.